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The glucose metabolite methylglyoxal inhibits
expression of the glucose transporter genes by
inactivating the cell surface glucose sensors Rgt2
and Snf3 in yeast
Adhiraj Roya,†, Salman Hashmia,†, Zerui Lia, Angela D. Dementb, Kyu Hong Choc,
and Jeong-Ho Kima,*
a
Department of Biochemistry and Molecular Medicine, George Washington University School of Medicine and Health
Science, Washington, DC 20037; bVirginia Bioinformatics Institute, Virginia Polytechnic Institute and State University,
Blacksburg, VA 24061; cDepartment of Biology, Indiana State University, Terre Haute, IN 47809

ABSTRACT Methylglyoxal (MG) is a cytotoxic by-product of glycolysis. MG has inhibitory effect on the growth of cells ranging from microorganisms to higher eukaryotes, but its molecular targets are largely unknown. The yeast cell-surface glucose sensors Rgt2 and Snf3 function as glucose receptors that sense extracellular glucose and generate a signal for induction
of expression of genes encoding glucose transporters (HXTs). Here we provide evidence that
these glucose sensors are primary targets of MG in yeast. MG inhibits the growth of glucosefermenting yeast cells by inducing endocytosis and degradation of the glucose sensors. However, the glucose sensors with mutations at their putative ubiquitin-acceptor lysine residues
are resistant to MG-induced degradation. These results suggest that the glucose sensors are
inactivated through ubiquitin-mediated endocytosis and degraded in the presence of MG. In
addition, the inhibitory effect of MG on the glucose sensors is greatly enhanced in cells lacking Glo1, a key component of the MG detoxification system. Thus the stability of these glucose sensors seems to be critically regulated by intracellular MG levels. Taken together, these
findings suggest that MG attenuates glycolysis by promoting degradation of the cell-surface
glucose sensors and thus identify MG as a potential glycolytic inhibitor.
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INTRODUCTION
Methylglyoxal (MG) is a reactive dicarbonyl compound formed by
nonenzymatic elimination of phosphate from the triose phosphates
of glycolysis, dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (G3P), in eukaryotic cells (Richard, 1984, 1993;
Phillips and Thornalley, 1993), as well as enzymatically from DHAP in
a reaction catalyzed by MG synthase in bacteria (Cooper and
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Anderson, 1970; Hopper and Cooper, 1972). Once formed, MG irreversibly modifies amino groups of proteins, nucleic acids, and
membrane lipids, forming advanced glycation end products
(Thornalley, 1998), which are associated with various pathologies,
including diabetes, aging-related disorders, and neurodegenerative
diseases (Desai et al., 2010; Rabbani and Thornalley, 2011; Beisswenger, 2014; Allaman et al., 2015). Cells are protected against
methylglyoxal toxicity by the glyoxalase system, which is composed
of two enzymes: glyoxalase I (Glo1), which metabolizes MG to S-dlactoylglutathione, and glyoxalase II (Glo2), which converts S-d-lactoylglutathione to d-lactate (Thornalley, 2003). MG appears to be the
major physiological substrate for Glo1. Overexpression of Glo1 prevents MG accumulation (Shinohara et al., 1998), whereas Glo1 inhibition increases MG accumulation, decreasing cellular viability
(Kuhla et al., 2006).
The budding yeast Saccharomyces cerevisiae prefers to ferment
rather than oxidize glucose, even when oxygen is abundant—
so-called aerobic glycolysis (Crabtree, 1929; Warburg, 1956;
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Lagunas, 1979). Because energy generation by fermentation of glucose is inefficient, yeast cells vigorously metabolize glucose by enhancing the rate-limiting step of glucose metabolism: its transport
(Johnston and Kim, 2005; Kim et al., 2013; Rolland et al., 2001).
Yeast cells have learned how to sense the amount of glucose that is
available and respond by expressing the most appropriate of its 17
glucose transporters (HXTs). They do this through a signal transduction pathway that begins at the cell surface with the Rgt2 and Snf3
glucose sensors and ends in the nucleus with the Rgt1 transcription
factor, which regulates expression of genes encoding glucose transporters (Kim et al., 2013).
Expression of HXT genes is repressed by the Rgt1 DNA–binding
repressor in the absence of glucose (Ozcan et al., 1996b). Rgt1 does
this by recruiting the HXT corepressors Mth1 and Std1 and the general corepressor complex Ssn6-Tup1 to the HXT promoters (Schmidt
et al., 1999; Kim et al., 2003, 2006; Kim, 2009; Lakshmanan et al.,
2003). When glucose is added to the glucose-starved cells, Mth1
and Std1 are phosphorylated by the plasma membrane–tethered
casein kinases Yck1 and Yck2 (YckI), ubiquitinated by the SCF-Grr1
ubiquitin-protein ligase, and subsequently degraded by the 26S
proteasome (Flick et al., 2003; Moriya and Johnston, 2004). This enables protein kinase A to access and phosphorylate Rgt1, resulting
in a disruption of the Rgt1 repressor complex and consequently in
derepression of HXT genes (Kim and Johnston, 2006; Palomino
et al., 2006; Jouandot et al., 2011; Roy et al., 2013, 2014). It is unclear how an intracellular signal that induces expression of HXT
genes is generated. However, YckI appears to be coupled to the
cell-surface glucose sensors Rgt2 and Snf3, leading to the current
view that glucose binding to the Rgt2 and Snf3 glucose sensors
causes them to activate YckI, which phosphorylates Mth1 and Std1,
which are bound to the C-terminal cytoplasmic tails of the sensors
(Moriya and Johnston, 2004; Johnston and Kim, 2005).
Extracellular glucose is sensed by Rgt2 and Snf3 at the plasma
membrane. These proteins are structurally similar to the Hxt glucose
transporters but seem to have lost the ability to transport glucose
inside the cell (Ozcan et al., 1996a). They function instead as receptors that monitor extracellular glucose. A dominant mutation in the
glucose sensors (R231K in Rgt2 and R229K in Snf3) leads to the
constitutive expression of HXT genes even in the absence of glucose, possibly converting the receptors into their glucose-bound
form (Ozcan et al., 1996a; Pasula et al., 2007). Thus it has been
proposed that glucose signaling by Rgt2 and Snf3 is a receptormediated process, similar to hormone signaling in mammalian cells
(Ozcan and Johnston, 1999; Johnston and Kim, 2005).
We recently reported that the glucose sensors are stable in cells
grown in glucose but endocytosed and degraded in the vacuole
when cells are starved of glucose (Roy and Kim, 2014). Of interest, it
was shown that constitutively active, signaling mutants of glucose
sensors are resistant to endocytosis, whereas signaling-defective
sensors are constitutively targeted for degradation. Thus the stability
of the glucose sensors may be correlated with their affinity for glucose. In this article, we give evidence that MG induces endocytosis
and degradation of the glucose sensors to inhibit expression of the
HXT genes and consequently attenuate glycolysis. We also discuss
the possible mechanisms by which MG regulates the stability of the
glucose sensors and the evaluation of MG as a glycolytic inhibitor.

RESULTS
Methylglyoxal inhibits expression of the yeast glucose
transporter genes (HXTs)
S. cerevisiae can use glucose efficiently over a broad range of concentrations. Accordingly, yeast cells have many different glucose
Volume 27 March 1, 2016

transporters, ∼17. Several of the glucose transporters are expressed
only when glucose is available and only under the appropriate conditions (Ozcan and Johnston, 1999). For example, the low-affinity
glucose transporter Hxt1 is only expressed when glucose is abundant, and the high-affinity glucose transporters Hxt2 and Hxt4 are
expressed only when glucose is scarce. HXT3, which encodes a glucose transporter of intermediate affinity, is expressed in cells exposed to both low (0.2%) and high (2%) levels of glucose (Ozcan
and Johnston, 1995). MG is a cytotoxic compound produced primarily as a by-product of glycolysis (Figure 1A), but its molecular
targets are largely unknown.
Raffinose is a trisaccharide consisting of fructose–glucose–galactose and for S. cerevisiae is equivalent to low glucose because it can
cleave the fructose–glucose bond only inefficiently and thus obtains
only low levels of glucose from it (Ozcan and Johnston, 1999). To
investigate the effect of MG on the viability of S. cerevisiae, we
treated the yeast cells grown in medium containing glucose or raffinose with different concentrations of MG. The results showed that
MG inhibits yeast cell growth in a dose-dependent manner, suggesting the possibility of an inhibitory effect of MG on glucose utilization (Figure 1B).
Next we examined directly the effect of MG on the expression of
the glucose transporter genes by measuring mRNA levels of Hxt1,
Hxt2, Hxt3, and Hxt4 transporters using quantitative real-time PCR
(qRT-PCR) with specific primers, as we described previously (Roy
et al., 2013). As mentioned, expression of HXT1 and HXT3 genes
is induced by high glucose, whereas that of HXT2 and HXT4 genes
is induced by low glucose (Figure 1D; see controls). However,
expression of all four HXT genes was inhibited by MG in a dosedependent manner, and >50% inhibition was achieved at a 10 mM
concentration of MG (Figure 1D).

Methylglyoxal decreases cell-surface levels of the Rgt2
and Snf3 glucose sensors
Rgt2 and Snf3 sense different levels of extracellular glucose and
function differently. Rgt2 is a low-affinity glucose sensor required for
induction of HXT1 by high glucose, whereas Snf3 is a high-affinity
sensor needed for the expression of HXT2 and HXT4 in response to
low levels of glucose (Ozcan et al., 1998; Ozcan and Johnston,
1996). Thus a yeast strain lacking these genes (rgt2Δsnf3Δ) grows
poorly on a glucose or raffinose (as low-glucose concentration) medium (Ozcan et al., 1996a). Given that MG seems to inhibit glucose
utilization by yeast, we examined whether it inactivates the Rgt2 and
Snf3 glucose sensors. Expression of Rgt2 in the rgt2snf3 double mutant restored growth in glucose medium but not in glucose medium
containing 10 mM MG. Similarly, Snf3 expression complemented
the growth defect of the rgt2Δsnf3Δ strain in raffinose medium but
not in raffinose medium containing 10 mM MG (Figure 2A). Thus
MG seems to decrease cell-surface levels of the glucose sensors.
The stability of the glucose sensors is correlated well with their
respective affinities; that is, Rgt2 remains stable at the plasma membrane only in high-glucose-grown yeast cells; by contrast, this holds
for Snf3 in yeast cells grown in low-glucose medium (Roy and Kim,
2014). Fluorescence microscopy and Western blot analysis confirmed that GFP-Rgt2 is stable in cells grown in high-glucose medium and endocytosed and subsequently degraded in the vacuole
when cells are starved of glucose and that, by contrast, GFP-Snf3 is
stable in cells in low-glucose medium and down-regulated when
cells are exposed to high-glucose or glucose-free medium (Figure 2,
B and C). Expression of the SNF3 gene is repressed about fivefold
by high levels of glucose, whereas the RGT2 gene is expressed
constitutively, being neither repressed nor induced by glucose
MG inhibits expression of HXT genes
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FIGURE 1: Methylglyoxal inhibits expression of the HXT genes. (A) Schematic representation of MG metabolism
pathways. MG is produced as a by-product of glycolysis by degradation of the triose phosphates DHAP and G3P. It is
then metabolized into d-lactate by glyoxalase systems (GLO1 and GLO2) or 1,2-propanediol by aldolase reductase
(GRE3). (B) Yeast cells (WT) were spotted on YP plates containing 2% glucose (Glucose) or 2% raffinose (Raffinose)
supplemented with different concentrations of MG as shown. The first spot of each row represents a count of 5 × 107
cells/ml, which is diluted 1:10 for each spot thereafter. The plates were incubated for 2 d and photographed. (C) This
figure has been removed by agreement of the authors and the journal’s Editorial Board because it contained incorrect
data. (D) qRT-PCR analysis of mRNA expressions of HXT1, HXT2, HXT3, and HXT4 genes. mRNA was isolated from yeast
cells (WT) grown in either 2% glucose (to quantify HXT1 and HXT3 gene expressions) or 2% raffinose (to quantify HXT2
and HXT4 gene expressions) containing the indicated amounts of MG. The data are averages of three independent
experiments, with error bars showing mean ± SD. *p < 0.05 and **p < 0.001.

(Ozcan et al., 1996a). We interrupted glucose regulation of expression of glucose sensor genes (SNF3 in particular) by replacing their
promoters with the promoter of MET25, which is not regulated by
glucose (Kim et al., 2006; Pasula et al., 2007). Therefore changes of
the GFP-Rgt2 and GFP-Snf3 levels in response to different glucose
concentrations might be due not to transcriptional repression but to
posttranslational regulation. We observed that GFP-Rgt2 and GFPSnf3 are removed from the plasma membrane and degraded in the
vacuole in response to MG (Figure 2D). These results suggest that
MG inhibits expression of HXT genes by decreasing cell-surface levels of the Rgt2 and Snf3 glucose sensors.

Methylglyoxal causes degradation of the Rgt2 and Snf3
glucose sensors
To further study MG-induced inactivation of the glucose sensors, we
conducted Western blot analysis of Rgt2 and Snf3 in the plasma
membrane fractions of yeast cells treated with different concentrations of MG. Because there is a possibility that the green fluorescent
protein (GFP) moiety of GFP-fused Rgt2 and Snf3 affects their MGinduced degradation, we expressed the glucose sensors, tagged
864 | A. Roy, S. Hashmi, et al.

with the 3x hemagglutinin (HA) epitope (27 amino acids), from their
own promoters. The results showed that the glucose sensor proteins
are degraded by MG in a concentration-dependent manner, and
>50% of degradation was achieved at 10 mM MG (Figure 3A). Next
we performed qRT-PCR of RGT2 and SNF3 genes in yeast cells
treated or not with MG and found that MG does not significantly
affect expression of either RGT2 or SNF3 (Figure 3B). Thus the disappearance of Rgt2-HA and Snf3-HA in response to MG treatment
is due to degradation but not to transcriptional repression, and this
was further confirmed by fluorescence microscopy of yeast cells expressing GFP-Rgt2 and GFP-Snf3 (Figure 3, C and D). We also observed that the amounts of immunodetected Rgt2-HA and Snf3-HA
were reduced by ∼50% within 100 min after yeast cells were treated
with 10 mM MG (Figure 3E).

Methylglyoxal induces endocytosis of the Rgt2
and Snf3 glucose sensors
Given that Rgt2 and Snf3 are inactivated by endocytosis, we examined whether MG-induced inactivation of the glucose sensors is due
to endocytosis, followed by degradation in the vacuole. Our results
Molecular Biology of the Cell

FIGURE 2: MG inactivates the yeast glucose sensors Rgt2 and Snf3. (A) Yeast cells (rgt2∆snf3∆) expressing empty
vector, Rgt2-HA (left) or Snf3-HA (right panel) were streaked on SC plates containing 2% glucose (Glucose) or 2%
raffinose (Raffinose), supplemented with or without 10 mM MG. The plates were incubated for 2 d and photographed.
(B) Yeast cells (WT) expressing GFP-Rgt2 or GFP-Snf3 were grown in SC medium containing 2% galactose (Gal) until mid
log phase (A600 nm = 1.2–1.5), and equal amounts of cells were shifted to SC medium containing 2% raffinose (Raf) or 2%
glucose (Glu). The distributions of the GFP fluorescence were analyzed by confocal microscopy. FM4-64 dye was used
to visualize vacuoles. (C) Western blot analysis of GFP-Rgt2 and GFP-Snf3 levels at the plasma membrane. Yeast cells
(WT) expressing GFP-Rgt2 or GFP-Snf3 were grown as described in B. Membrane fractions were analyzed using
anti-GFP and anti-actin antibodies. (D) Yeast cells (WT) expressing GFP-Rgt2 or GFP-Snf3 were grown in SC medium
containing 2% glucose (GFP-Rgt2) or 2% raffinose (GFP-Snf3) until mid log phase and treated with 10 mM MG for 2 h.
The distributions of the GFP fluorescence were analyzed by confocal microscopy. Actin served as a loading control in C.

showed that MG treatment decreases the protein levels of Rgt2-HA
and Snf3-HA in wild-type yeast cells but not in yeast cells lacking
End3, a protein involved in the internalization step of endocytosis,
which suggests that MG induces endocytosis of Rgt2 and Snf3
(Figure 4, A and C). This was confirmed by confocal microscopy
showing that GFP-Rgt2 and GFP-Snf3 are removed from the plasma
membrane and targeted to the vacuole for degradation in response
to MG in wild-type yeast cells but not in the end3Δ mutant cells
(Figure 4, B and D).

Methylglyoxal may promote Rsp5-dependent degradation
of the Rgt2 and Snf3 glucose sensors
Ubiquitination is a common signal for endocytosis and subsequent
degradation of plasma membrane proteins (Hicke and Dunn,
2003). A number of yeast nutrient transporters are ubiquitinated
by the ubiquitin ligase Rsp5, and this process is affected by the
ubiquitin isopeptidase Doa4, which is required for recycling ubiquitin from ubiquitinated substrates (Springael and Andre, 1998;
Amerik et al., 2000; Rotin et al., 2000). Rsp5 is involved in degradation of the Rgt2 glucose sensor (Roy and Kim, 2014). Thus we
examined the role of Rsp5 in the MG-induced endocytosis and
degradation of glucose sensors. Western blot analysis showed that
Rgt2-HA and Snf3-HA levels are decreased in response to MG in
Volume 27 March 1, 2016

wild-type cells but not in doa4Δ or rsp5-1ts mutant cells (Figure 5,
A and B). Thus Rgt2 and Snf3 accumulated in the plasma membrane of the yeast mutants, regardless of the treatment of MG
(Figure 5, C and D). We previously identified Lys-637 and Lys-657
of Rgt2 as putative ubiquitination sites (Roy and Kim, 2014). The
Rgt2K637A,K657A mutant is resistant to MG-induced degradation
(Figure 5E), and its expression allows yeast cells to grow on MGcontaining medium (Figure 5F). These results suggest that MG induces Rsp5-dependent endocytosis and vacuolar targeting of the
glucose sensors.

Glo1 plays an essential role in the growth of yeast
in the presence of methylglyoxal
MG, both exogenously supplied and endogenously produced via
glycolysis, is detoxified by the glyoxalase system. In yeast, MG is
metabolized by two pathways (Figure 1A): the glutathione-dependent glyoxalase pathway and the NADPH-dependent aldose reductase pathway (Aguilera and Prieto, 2001; Vander Jagt et al.,
2001; Chen et al., 2003). The glyoxalase pathway consists of the
enzymes glyoxalase I (Glo1), which catalyzes the formation of S-dlactoylglutathione from methylglyoxal, and reduced glutathione
(GSH) and glyoxalase II (Glo2), which recycles GSH and releases
d-lactate (Martins et al., 2001a,b). Aldose reductase, encoded by
MG inhibits expression of HXT genes
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FIGURE 3: MG induces posttranslational down-regulation of Rgt2 and Snf3 in a dose-dependent manner. (A) Western
blot analysis of Rgt2-HA (top) and Snf3-HA (bottom) levels at the plasma membrane. Yeast cells (WT) expressing
Rgt2-HA or Snf3-HA were grown in SC-2% glucose or SC-2% raffinose medium, respectively, until mid log phase
(A600 nm = 1.2–1.5), and equal amounts of cells were shifted to SC medium containing the indicated concentrations of
MG for 2 h. Membrane fractions were analyzed using anti-HA and anti-Pma1 antibodies. (B) qRT-PCR analysis of mRNA
expressions (mRNA, closed circles) of RGT2 (top) and SNF3 (bottom) in yeast cells grown as described in A;
densitometric quantification of the intensities of each of the bands on the blot in A (protein, open circles). (C) Yeast cells
(WT) expressing GFP-Rgt2 or GFP-Snf3 were grown as described in A, and the distributions of the GFP fluorescence
were analyzed by confocal microscopy. (D) Quantification of the GFP fluorescence intensities of plasma membrane (PM)
from the cells depicted in C; box-and-whiskers plot (n >150). The horizontal midline represents the median; the box is
bounded by the upper and lower quartiles; the whiskers denote the maximum and minimum fluorescence intensities
with 5th and 95th percentiles. (E) Yeast cells (WT) expressing Rgt2-HA or Snf3-HA were grown in SC-2% glucose or
SC-2% raffinose medium, respectively, until mid log phase (A600 nm = 1.2–1.5) and shifted to SC medium containing
10 mM MG for the times as indicated. Membrane fractions were immunoblotted with anti-HA and anti-Pma1 antibodies
(left), and half-lives of Rgt2-HA and Snf3-HA were calculated as described in Materials and Methods (right). Pma1 served
as a loading control in A and E.

Gre3, catalyzes the two-step reduction of methylglyoxal to 1,2-propanediol, with acetol (hydroxyacetone) as an intermediate (Chen
et al., 2003). Thus the glo1Δ mutant was more sensitive to MG
than the wild-type strain (Figure 6A), as reported previously (Maeta
et al., 2005). Of greater importance, the Rgt2 and Snf3 glucose
sensors are more sensitive to exogenous MG in the glo1∆ mutant,
where intracellular MG is not efficiently metabolized, than in wildtype yeast, consistent with the result that the glucose sensors are
primary targets of MG (Figure 6, B and C).

DISCUSSION
MG is a cytotoxic metabolite formed as a by-product of glycolysis, but
its targets are largely unknown. In this study, we found that MG inhibits
expression of the HXT glucose transporter genes by inactivating the
yeast glucose sensors Rgt2 and Snf3, which generate a signal for HXT
866 | A. Roy, S. Hashmi, et al.

expression in response to glucose. Several lines of evidence indicate
that MG induces endocytosis and degradation of the glucose sensors:
1) they are removed from the plasma membrane and targeted to the
vacuole for degradation in response to MG (Figures 2 and 3); 2) MGinduced degradation of these sensor proteins requires End3, Doa4, or
active Rsp5 (Figures 4 and 5); and 3) glucose sensors with mutations
at the putative ubiquitination sites are resistant to MG-induced endocytosis (Figure 5). The Rgt2 and Snf3 glucose sensors are essential for
yeast cells to grow on glucose as sole carbon source. Our findings
suggest that MG inhibits the growth of glucose-fermenting yeast cells
by promoting degradation of the glucose sensors.
It is unknown how MG induces endocytosis of the glucose sensors, but our recent findings might provide a clue to the role of
MG in regulation of these sensor proteins (Roy and Kim, 2014).
The glucose sensors undergo a conformational change from an
Molecular Biology of the Cell

glucose-induced conformational change of
the glucose sensors, keeping them in the
inactive state and thereby targeting them
to the vacuole. Our evidence shows that
endocytosis of these proteins requires the
Rsp5 ubiquitin ligase. Thus it is conceivable
that MG directly or indirectly modifies Rgt2
and Snf3, making them accessible to Rsp5.
In yeast, MG enters the cell via the Fps1
plasma membrane channel (Mollapour and
Piper, 2007), and it is detoxified by the glyoxalase system (e.g., Glo1; Figure 1A). Our
data show that the inhibitory effect of MG
on the glucose sensors is greatly enhanced
in the glo1Δ mutant, where MG accumulates (Figure 6). This suggests that degradation of Rgt2 and Snf3 is stimulated by intracellular MG. We cannot exclude the
possibility that MG inhibits binding of glucose to the glucose sensors, keeping them
in glucose-unbound form and vulnerable to
degradation. However, this hypothesis is
less tenable, in that the stability of Rgt2 and
Snf3 is regulated by intracellular MG. In
summary, our results suggest that MG prevents glucose-fermenting yeast cells from
using glucose as sole carbon source by inhibiting expression of the HXT genes and
thus identify MG as a glycolytic inhibitor.
Intracellular MG concentrations are elevated under conditions of increased glycolytic flux, such as aerobic glycolysis associated with malignant transformation (Kawase
et al., 1996). These observations suggest
that exogenous supply of MG in combination with pharmacological inhibitors of Glo1
may be an effective way to target cancer
cells, which heavily rely on glycolysis for
energy.
FIGURE 4: MG induces endocytosis of Rgt2 and Snf3. (A) Western blot analysis of Rgt2-HA
levels at the plasma membrane. Yeast cells (WT and end3∆) expressing Rgt2-HA were grown as
described in Figure 3A. Membrane fractions were immunoblotted with anti-HA antibody (top).
The intensities of each band on the blots were quantified by densitometric scanning (bottom;
*p < 0.05 and **p < 0.001). (B) Yeast cells (WT and end3∆) expressing GFP-Rgt2 were grown as
described in Figure 2D. Confocal microscopy images (top) and quantifications of the GFP
fluorescence intensities (bottom) as described in Figure 3D. (C) Western blot analysis of Snf3-HA
levels at the plasma membrane was performed as described in A. Membrane fractions were
immunoblotted with anti-HA antibody (top). The intensities of each band on the blots were
quantified by densitometric scanning (bottom). (D) Confocal microscopy analysis of localization
of GFP-Snf3 was carried out as described in B.

inactive to an active state upon glucose binding (Thevelein and
Voordeckers, 2009). The active form (glucose bound) of these proteins localizes and functions at the plasma membrane, whereas the
inactive ones (glucose unbound) are targeted to the vacuole for
degradation. This notion is supported by the findings that Rgt2
and Snf3 are stabilized at the plasma membrane only when the
extracellular glucose concentration is in the range of their respective affinities and that constitutively active mutants of Rgt2 and
Snf3 sensors are not down-regulated even when glucose is absent
(Roy and Kim, 2014). We hypothesize that MG may inhibit the
Volume 27 March 1, 2016

MATERIALS AND METHODS
Yeast strains and growth conditions
The S. cerevisiae strains used in this study
are listed in Table 1. Cells were grown in YP
(2% bactopeptone, 1% yeast extract) and
SC (synthetic yeast nitrogen base medium
containing 0.17% yeast nitrogen base and
0.5% ammonium sulfate) media supplemented with appropriate amino acids and
carbon sources. The plasmids used in this
study are listed in Table 2.

Yeast membrane preparation, Western blotting, and protein
half-life measurement
Membrane-enriched fractions were essentially prepared as described previously (Galan et al., 1996). Briefly, cells expressing
Rgt2-HA, Snf3-HA, Rgt2K637A K657A-HA, GFP-Rgt2, and GFP-Snf3
were cultured in 200-ml conical flasks containing 50 ml of SC
medium to mid log phase (A600 nm = 1.2–1.5), treated with different concentrations of MG (0–20 mM), and further incubated for
0–120 min, as indicated in the figures. The cells were harvested
and washed with phosphate buffer, pH 7.4, containing 10 mM
MG inhibits expression of HXT genes

| 867

FIGURE 5: Rsp5 ubiquitin ligase is required for MG-induced vacuolar targeting and degradation of Rgt2 and Snf3.
(A) Western blot analysis of Rgt2-HA levels at the plasma membrane. Yeast cells (WT, doa4∆ and rsp5-1) expressing
Rgt2-HA were grown as described in Figure 2D. Membrane fractions were immunoblotted with anti-HA and anti-Pma1
antibodies. (B) Western blot analysis of Snf3-HA levels at the plasma membrane was performed as described in A.
(C) Yeast cells (WT, doa4∆ and rsp5-1) expressing GFP-Rgt2 or GFP-Snf3 were grown as described in Figure 2D. The
distributions of the GFP intensities were analyzed by confocal microscopy. (D) Quantification of the GFP fluorescence
intensities from the cells depicted in C; box-and-whiskers plot (n > 150). (E) Western blot analysis of Rgt2-HA or
Rgt2K637A K657A-HA levels at the plasma membrane. Yeast cells (rgt2∆snf3∆) expressing Rgt2-HA or Rgt2K637A K657A-HA
were grown in SC-2% glucose medium until mid log phase (A600 nm = 1.2–1.5) and shifted to SC medium containing
10 mM MG for 2 h. Membrane fractions were immunoblotted with anti-HA and anti-Pma1 antibodies. (F) Yeast cells
(rgt2∆snf3∆) expressing Rgt2-HA or Rgt2K637A K657A-HA were streaked on YP plates containing 2% glucose (Glucose),
supplemented with or without 10 mM MG. The plates were incubated for 2 d and photographed. Pma1 served as a
loading control in A, B, and E.

sodium azide, and the cell pellets were resuspended in ice-cold
membrane isolation buffer (100 mM Tris-Cl, pH 8, 150 mM NaCl,
5 mM EDTA) containing 10 mM sodium azide and protease and
phosphatase inhibitors and vortexed with acid-washed glass
beads. The samples were diluted with the same buffer, and cell
debris was removed by centrifugation. The membrane-enriched
fractions were collected by centrifuging the samples at 12,000
rpm for 40 min at 4°C. The proteins were precipitated with 10%
trichloroacetic acid, neutralized with 20 μl of 1 M Tris base, and
finally dissolved in 80 μl of SDS buffer (50 mM Tris-Cl, pH 6.8,
868 | A. Roy, S. Hashmi, et al.

10% glycerol, 2% SDS, 5% β-mercaptoethanol). The proteins
were resolved by 8% SDS–PAGE and transferred to polyvinylidene fluoride membranes (Millipore, Billerica, MA), and the
membranes were incubated with appropriate antibodies (antiHA, anti-GFP, anti-actin, or anti-Pma1 antibody; Santa Cruz Biotechnology, Santa Cruz, CA) in TBST buffer (10 mM Tris-Cl, pH
7.5, 150 mM NaCl, 0.1% Tween 20), and the immunoreactive
bands were visualized by enhanced chemiluminescence (Pierce,
Rockford, IL). The half-lives of Rgt2-HA and Snf3-HA were measured as described previously (Belle et al., 2006). Briefly, the
Molecular Biology of the Cell

qRT-PCR
Total RNA was extracted by an RNeasy
minikit (Qiagen, Valencia, CA) following the
manufacturer’s protocol, and 2 μg of total
RNA was converted to cDNA by qScript
cDNA supermix (Quanta Biosciences,
Gaithersburg, MD). cDNA was analyzed by
qRT-PCR2 using SsoFast Evagreen reagent
(Bio-Rad, Hercules, CA) in a CFX96 RealTime Thermal Cycler (Bio-Rad). ACT1 was
used as an internal control to normalize expression of HXT1-4 RGT2, and SNF3
genes. All of the quantification data shown
are the averages of three independent experiments, with error bars representing SD.
Statistical significance was calculated by
Student’s t test using SigmaPlot software.
*p < 0.05 and **p < 0.001 as compared
with control.

Fluorescence microscopy
and quantification
The GFP-tagged glucose sensors Rgt2 and
Snf3 were imaged using a spinning-disk
confocal microscope (Carl Zeiss) fitted with
an Apo 150× glycerol objective (numerical
aperture, 1.35). The cells were grown in SC
medium supplemented with 2% galactose,
2% glucose, or 2% raffinose to mid log
phase (A600 nm = 1.2–1.5), and MG was
added to a final concentration of 0–20 mM.
The cells were further incubated for
0–120 min, as indicated in the figures, before imaging. Cells were plated onto glassbottom dishes (Greiner Bio One, Monroe,
NC) and allowed to settle for 5 min before
imaging. All images from an experiment
were captured with identical imaging parameters and equivalently adjusted using
Adobe Photoshop software. To visualize
FIGURE 6: Inactivation of GLO1 gene causes rapid down-regulation of Rgt2 and Snf3.
vacuoles, cells were first incubated with
(A) Yeast cells (WT, glo1∆ and gre3∆) were spotted on YP plates containing 2% glucose
1.6 μM FM 4-64 dye for 30 min and then
(Glucose) or 2% raffinose (Raffinose) supplemented with the indicated concentrations
pelleted and resuspended in fresh meof MG, as described in Figure 1B. The plates were incubated for the indicated time and
dium without FM 4-64. The images were
photographed. (B) Western blot analysis of Rgt2-HA at the plasma membrane. Yeast cells
captured using a Texas red filter. The fluo(WT and glo1∆) expressing Rgt2-HA were grown in SC medium containing 2% glucose until
rescence intensities of GFP-Rgt2 and GFPmid log phase and treated with the indicated concentrations of MG for 2 h. Membrane
Snf3 were quantified using ImageJ, verfractions were immunoblotted with anti-HA and anti-Pma1 antibodies (left). (C) Western blot
analysis of Snf3-HA at the plasma membrane. Yeast cells (WT and glo1∆) expressing Snf3-HA sion 1.4r, software. For the quantification
of fluorescence at the cell surface, the
were grown in SC medium containing 2% raffinose until mid log phase and treated with the
mean pixel intensities of the plasma memindicated concentrations of MG for 2 h. Membrane fractions were immunoblotted with
anti-HA and anti-Pma1 antibodies (left). The intensities of each band on the blots in B and
brane in each of at least 150 cells were
C were quantified by densitometric scanning (right). Pma1 served as a loading control in B
measured, and the mean background
and C.
pixel intensities were subtracted. The distributions of mean pixel intensities (in arbiband intensities were quantified by densitometry using ImageJ,
trary units) are presented as box-and-whiskers plots generated by
version 1.4r, software (National Institutes of Health, Bethesda,
SigmaPlot, version 12, software. For all bar plots, each mean
MD) and normalized with the intensities of Pma1. The numbers
value represents the average for a minimum of three independent
obtained from the control samples (without MG treatment) were
experiments. SDs were calculated and are shown as error bars.
converted to 100, and all the values were plotted on a semilogaStatistical significance was calculated by Student’s t test using
rithmic graph against time and further fitted to an exponential
SigmaPlot software. *p < 0.05 and **p < 0.001 as compared with
line.
control.
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Strain

Genotype

Source

BY4741

Mata his3Δ1 leu2Δ0 ura3Δ0
met15Δ

Kaniak et al. (2004)

YM 6870

MATa his3∆1 leu2∆0
ura3∆0 met15∆0 LYS2
rgt2::kanMX::natMX
snf3::kanMX

Kaniak et al. (2004)

KFY 122

Matα his3Δ1 leu2Δ0 ura3Δ0
doa4::KanMX

Roy and Kim (2014)

KFY 123

Mata his3Δ1 leu2Δ0 ura3Δ0
RSP5

Liu et al. (2007)

KFY 124

Mata his3Δ1 leu2Δ0 ura3Δ0
rsp5-1/smm1

Liu et al. (2007)

KFY 127

Matα his3Δ1 leu2Δ0 ura3Δ0
end3::KanMX

Roy and Kim (2014)

KFY 165

Matα his3Δ1 leu2Δ0 ura3Δ0
glo1::KanMX

This study

KFY 166

Matα his3Δ1 leu2Δ0 ura3Δ0
gre3::KanMX

This study

TABLE 1: Yeast strains used in this study.

Plasmid
name

Description

Source

KFP69

pAD80, 3x-HA-CYC1
terminator, Leu2, 2 μ

Kim (2009)

JKP251

pAD80-PRGT2-Rgt2-3xHA

Roy and Kim (2014)

JKP293

pUG34-PMET25-GFP-Rgt2, His3,
CEN

Roy and Kim (2014)

JKP298

pAD80-PSNF3-Snf3-3xHA

Roy and Kim (2014)

JKP308

pAD80-PRGT2-Rgt2 (K637A,
K657A)-3xHA

Roy and Kim (2014)

JKP309

pUG34-PMET25-GFP-Snf3, His3,
CEN

Roy and Kim (2014)

TABLE 2: Plasmids used in this study.
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